Invitrogen, Sentigen Holding Corp. deal

IVGN said it plans to acquire the company for $3.37 per share, or $25.9 million in cash. The deal price is a 23% premium to SGHL close of $2.75 on Aug. 31, the day before the deal was announced. IVGN ...